Rockwell Medical (RMTI) EPS (Weighted Average and Diluted) (2016 - 2025)
Historic EPS (Weighted Average and Diluted) for Rockwell Medical (RMTI) over the last 16 years, with Q3 2025 value amounting to -$0.05.
- Rockwell Medical's EPS (Weighted Average and Diluted) fell 22500.0% to -$0.05 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.18, marking a year-over-year decrease of 20000.0%. This contributed to the annual value of -$0.02 for FY2024, which is 9517.91% up from last year.
- Per Rockwell Medical's latest filing, its EPS (Weighted Average and Diluted) stood at -$0.05 for Q3 2025, which was down 22500.0% from -$0.05 recorded in Q2 2025.
- In the past 5 years, Rockwell Medical's EPS (Weighted Average and Diluted) ranged from a high of $0.04 in Q3 2024 and a low of -$1.04 during Q4 2021
- Over the past 5 years, Rockwell Medical's median EPS (Weighted Average and Diluted) value was -$0.07 (recorded in 2023), while the average stood at -$0.31.
- Its EPS (Weighted Average and Diluted) has fluctuated over the past 5 years, first tumbled by 105555.56% in 2021, then surged by 15714.29% in 2024.
- Quarter analysis of 5 years shows Rockwell Medical's EPS (Weighted Average and Diluted) stood at -$1.04 in 2021, then soared by 95.19% to -$0.05 in 2022, then increased by 0.0% to -$0.05 in 2023, then skyrocketed by 49.84% to -$0.03 in 2024, then crashed by 99.35% to -$0.05 in 2025.
- Its EPS (Weighted Average and Diluted) was -$0.05 in Q3 2025, compared to -$0.05 in Q2 2025 and -$0.04 in Q1 2025.